Drugs / GXNPC1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04088149 | Feb 2020 → Aug 2023 | stroke disorder | Gwo Xi Stem Cell Applied Technology Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GXNPC1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04088149 ↗ |
| Modality | Cell therapy | “Autologous ADSCs” NCT04088149 ↗ |